Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.53%-31.8M | 102.27%476K | -208.80%-55.06M | -382.90%-152.43M | -3,777.85%-86.83M | -386.81%-26.83M | -394.36%-20.94M | 26.26%-17.83M | -117.84%-31.57M | -73.45%2.36M |
| Net income from continuing operations | -74.21%28.06M | -58.25%28.1M | 262.94%118.25M | -39.34%179.12M | 245.70%75.56M | 2.27%108.83M | -21.21%67.3M | -188.93%-72.57M | -7.94%295.29M | -46.71%21.86M |
| Operating gains losses | 77.76%-17.94M | 76.30%-15.23M | -209.33%-106.97M | 37.13%-117.85M | -953.30%-70.76M | 0.48%-80.67M | -38.37%-64.26M | 283.78%97.84M | 31.77%-187.45M | 60.33%-6.72M |
| Depreciation and amortization | 1,802.18%19.21M | 2,063.95%14.89M | 1,802.64%14.42M | 756.95%19.67M | 3,301.38%17.21M | 43.47%1.01M | 13.16%688K | 58.91%758K | -60.90%2.3M | 6.08%506K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | -219.83%-2.24M | -287.96%-1.44M | -88.93%119K | -39.70%2.04M | 43.11%903K | -142.56%-701K | 256.56%764K | -32.60%1.08M | -6.67%3.39M | -46.07%631K |
| Remuneration paid in stock | -17.46%6.19M | -47.71%4.45M | -72.93%2.42M | -4.61%27.92M | -61.41%2.98M | 11.47%7.5M | 19.45%8.51M | 15.98%8.93M | 7.54%29.27M | -1.20%7.72M |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cashItems | 58.85%-24.56M | -16.23%-34.84M | 37.20%-33.53M | 4.26%-192.32M | 0.13%-49.26M | -24.15%-59.69M | 46.72%-29.98M | -13.09%-53.39M | -376.92%-200.87M | 21.92%-49.32M |
| Change In working capital | -326.10%-6.3M | 245.17%4.68M | -795.45%-43.52M | -863.05%-64.99M | -315.12%-55.43M | -139.48%-1.48M | -347.20%-3.22M | 78.20%-4.86M | 36.12%8.52M | -13.85%25.77M |
| -Change in receivables | -163.22%-37.27M | -85.52%-22.83M | -50.79%-14.41M | -188.65%-48.35M | -439.95%-12.33M | -8.27%-14.16M | -58.22%-12.31M | -2,103.56%-9.56M | -231.92%-16.75M | -40.06%3.63M |
| -Change in inventory | 182.07%16.26M | 131.13%6.79M | 257.73%2.66M | -14,841.57%-76.2M | -4,839.79%-32.9M | -198,040.00%-19.81M | -23,795.65%-21.8M | -2,382.43%-1.69M | -3,087.50%-510K | -608.51%-666K |
| -Change in prepaid assets | -142.88%-3.12M | 74.93%6.87M | -138.95%-5.21M | 243.99%30.99M | 246.54%6.42M | 186.36%7.27M | 282.39%3.93M | 303.53%13.37M | 8.50%-21.52M | 65.75%-4.38M |
| -Change in payables and accrued expense | -29.35%17.82M | -48.60%13.86M | -280.12%-26.56M | -39.57%28.58M | -161.13%-16.62M | -0.08%25.23M | 141.99%26.96M | 57.07%-6.99M | 35.77%47.3M | -26.01%27.19M |
| Interest paid (cash flow from operating activities) | -909.60%-41.65M | -312.46%-8.57M | -381.88%-9.98M | -487.04%-17.71M | -232.93%-9.43M | -6,345.31%-4.13M | -3,198.41%-2.08M | -3,596.43%-2.07M | -2,039.01%-3.02M | -5,566.00%-2.83M |
| Interest received (cash flow from operating activities) | 193.57%7.44M | 96.59%8.14M | 8.28%7.01M | -30.79%14.98M | -52.81%1.84M | -43.37%2.53M | -30.77%4.14M | -11.34%6.47M | 48.36%21.65M | -49.06%3.89M |
| Tax refund paid | 62.50%-12K | 110.98%308K | -16,345.00%-3.29M | -429.86%-3.3M | -30.97%-444K | -23.08%-32K | -1,229.38%-2.81M | 57.45%-20K | -4,692.31%-623K | ---339K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.53%-31.8M | 102.28%477K | -208.79%-55.06M | -382.90%-152.43M | -3,777.85%-86.83M | -386.81%-26.83M | -394.36%-20.94M | 26.25%-17.83M | -117.84%-31.57M | -73.45%2.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -24.56%-150.2M | 38.23%-87.43M | 45.98%-75.29M | -3.86%-495.41M | 34.15%-93.9M | 13.83%-120.58M | -9.66%-141.55M | -113.10%-139.38M | -174.71%-477M | -82.41%-142.59M |
| Net PPE purchase and sale | 31.30%-81.57M | 35.90%-88.32M | 49.04%-70.72M | -4.03%-491.59M | 31.35%-96.29M | 14.59%-118.74M | -7.40%-137.79M | -113.64%-138.77M | -198.07%-472.55M | -80.61%-140.27M |
| Net business purchase and sale | -378,744.44%-68.19M | -15.38%-15K | ---1K | 1,802.27%749K | 7,900.00%780K | -125.00%-18K | 18.75%-13K | --0 | -12.82%-44K | 0.00%-10K |
| Net investment purchase and sale | --0 | --2.35M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | 76.26%-433K | 61.31%-1.45M | -647.46%-4.57M | -3.70%-4.57M | 169.73%1.61M | -104.26%-1.82M | -392.75%-3.74M | -38.55%-611K | -154.75%-4.4M | -367.41%-2.31M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -24.56%-150.2M | 38.23%-87.43M | 45.98%-75.29M | -3.86%-495.41M | 34.15%-93.9M | 13.83%-120.58M | -9.66%-141.55M | -113.10%-139.38M | -174.71%-477M | -82.41%-142.59M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 618.25%556.72M | 4,734.76%42.27M | 135,446.46%726.53M | -58.63%206.95M | -68.10%129.81M | 35.68%77.51M | -102.59%-912K | -44.46%536K | 5,326.39%500.27M | 6,677.00%406.99M |
| Net issuance payments of debt | -84.20%12.25M | 356.88%40.1M | 69,161.09%747.24M | 128.39%220.14M | 14,082.69%134.93M | 34.71%77.51M | -77.99%8.78M | -1,445.71%-1.08M | 13,599.30%96.39M | -364.38%-965K |
| Net common stock issuance | --564.49M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --429.7M | ---- |
| Cash dividends paid | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | 190.00%29K | 520.50%2.48M | --0 | -31.54%3.5M | 200.00%1.47M | -99.08%10K | -83.99%400K | 56.33%1.62M | -7.47%5.11M | -22.87%489K |
| Interest paid (cash flow from financing activities) | --0 | --0 | ---- | 29.77%-10.1M | --0 | ---7K | -40.36%-10.09M | ---- | 0.00%-14.38M | 0.00%-7.19M |
| Net other financing activities | ---20.05M | ---313K | ---20.71M | 60.18%-6.59M | ---- | ---- | ---- | ---- | ---16.55M | ---15.06M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 618.25%556.72M | 4,734.76%42.27M | 135,446.46%726.53M | -58.63%206.95M | -68.10%129.81M | 35.68%77.51M | -102.59%-912K | -44.46%536K | 5,326.39%500.27M | 6,677.00%406.99M |
| Net cash flow | ||||||||||
| Beginning cash position | 171.22%668.21M | 74.39%717M | -79.57%117.34M | -3.88%574.29M | -40.68%179.93M | -37.29%246.37M | -17.30%411.13M | -3.88%574.29M | -1.76%597.45M | -54.28%303.31M |
| Current changes in cash | 636.12%374.72M | 72.65%-44.69M | 480.52%596.18M | -5,215.78%-440.89M | -119.09%-50.92M | 20.85%-69.9M | -66.53%-163.4M | -76.80%-156.67M | -33.02%-8.29M | 453.48%266.76M |
| Effect of exchange rate changes | 266.48%12.66M | 53.85%-630K | 153.54%3.47M | -8.05%-16.06M | -375.63%-11.66M | 372.05%3.46M | 77.76%-1.37M | 44.49%-6.49M | -231.02%-14.86M | -55.78%4.23M |
| End cash Position | 486.68%1.06B | 172.63%671.68M | 74.39%717M | -79.57%117.34M | -79.57%117.34M | -40.68%179.93M | -37.29%246.37M | -17.30%411.13M | -3.88%574.29M | -3.88%574.29M |
| Free cash from | 22.15%-113.37M | 43.24%-90.1M | 19.67%-125.81M | -26.44%-644.14M | -32.36%-183.17M | -0.75%-145.63M | -19.76%-158.74M | -66.64%-156.61M | -2,881.53%-509.47M | -101.11%-138.39M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.